DESPARBES ERIC (Chief Financial Officer) received a stock award from BIORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/17/2023ACC: 0000899243-23-009032
Officer· Chief Financial Officer
Since Jun 2020
+73.70K
Net shares
Net buyer
$28.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
84.92K acquired · 11.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+62.23K
Price / share
—
Trade value
—
% of position
221.1%
3/15/2023
28.14K→90.36K
Common Stock
Direct
Shares
+22.69K
Price / share
—
Trade value
—
% of position
25.1%
3/15/2023
90.36K→113.06K
Common Stock
Direct
Shares
−11.22K
Price / share
$2.56
Trade value
$28.71K
% of position
9.9%
3/15/2023
113.06K→101.84K
Total
Net shares
+73.70K
Net value
-$28.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2023 | A · Award | +62.23K | — | — | 221.1% | 28.14K | 90.36K |
| Common Stock Direct | 3/15/2023 | A · Award | +22.69K | — | — | 25.1% | 90.36K | 113.06K |
| Common Stock Direct | 3/15/2023 | F · Tax Withholding | −11.22K | $2.56 | $28.71K | 9.9% | 113.06K | 101.84K |
| Total | +73.70K | -$28.71K | ||||||
Derivative Transactions0
No derivative transactions reported